On Saturday, August 1, 2020 at 1:12:49 AM UTC+2, Jason wrote: > > There have been 65 studies on HCQ. Of all the tests that looked at giving > it early in the disease, or prophylactically, they showed HCQ was > beneficial. This site summarizes them all: https://c19study.com/ > > The only studies that have shown HCQ to be ineffective are those where it > is given late in the disease progression (when the disease shifts from the > viral > replication phase to an immune system dysregulation phase > <https://www.evms.edu/media/evms_public/departments/internal_medicine/EVMS_Critical_Care_COVID-19_Protocol.pdf> > > (see page 2)). Even then, 61% of studies have shown some effectiveness even > when it is given late. > > Given the well-established safety > <https://www.cdc.gov/malaria/resources/pdf/fsp/drugs/Hydroxychloroquine.pdf> > record of HCQ, this is the dilemma we face: > > HCQ works HCQ doesn't work > HCQ widely dispensed 10,000s of thousands of lives saved $20 wasted per > patient > HCQ use restricted 10,000s of thousands of needless deaths $0 wasted per > patient > > Even in the face of impartial information on its effectiveness, the > decision is clear. >
https://www.who.int/news-room/detail/04-07-2020-who-discontinues-hydroxychloroquine-and-lopinavir-ritonavir-treatment-arms-for-covid-19 Why not find out from the WHO or the steering committee itself? Just be prepared to wait as I believe they are somewhat busy. But contact them if you feel the need. PGC -- You received this message because you are subscribed to the Google Groups "Everything List" group. To unsubscribe from this group and stop receiving emails from it, send an email to [email protected]. To view this discussion on the web visit https://groups.google.com/d/msgid/everything-list/3aec74a0-08c9-4b92-b784-62d3abd223e6o%40googlegroups.com.
